Literature DB >> 22326193

Percutaneous coronary intervention use in the United States: defining measures of appropriateness.

Steven P Marso1, Paul S Teirstein, Dean J Kereiakes, Jeffrey Moses, John Lasala, J Aaron Grantham.   

Abstract

Appropriate utilization of percutaneous coronary intervention (PCI) and medical therapy is deservedly a national healthcare policy priority for the United States. Because PCI is both common and costly, appraisal of appropriateness is warranted. The initial appropriate use criteria (AUC) have been developed for coronary revascularization procedures and investigators recently reported the appropriateness for the approximately 500,000 PCI procedures performed at centers participating in the National Cardiovascular Data Registry. The AUC have broad implications for both healthcare providers and our patients and will be used as the basis for indications, referral patterns, treatment options, physician education, shared decision-making, and reimbursement for years to come. While we acknowledge the importance of thoughtfully assessing appropriateness for all medical procedures including PCI, there are a number of concerns with the current AUC and methods used to report appropriateness that warrant expanded commentary.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22326193     DOI: 10.1016/j.jcin.2011.12.004

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

1.  Quality of life benefits of percutaneous coronary intervention for chronic occlusions.

Authors:  David M Safley; J Aaron Grantham; Jason Hatch; Philip G Jones; John A Spertus
Journal:  Catheter Cardiovasc Interv       Date:  2013-12-19       Impact factor: 2.692

2.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.

Authors:  Manesh R Patel; John H Calhoon; Gregory J Dehmer; James Aaron Grantham; Thomas M Maddox; David J Maron; Peter K Smith
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

3.  Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study.

Authors:  Anjan K Chakrabarti; Maria V Grau-Sepulveda; Sean O'Brien; Cassandra Abueg; Angelo Ponirakis; Elizabeth Delong; Eric Peterson; Lloyd W Klein; Kirk N Garratt; William S Weintraub; C Michael Gibson
Journal:  Circ Cardiovasc Interv       Date:  2014-02-04       Impact factor: 6.546

4.  Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR.

Authors:  Steven M Bradley; Paul S Chan; John A Spertus; Kevin F Kennedy; Pamela S Douglas; Manesh R Patel; H Vernon Anderson; Henry H Ting; John S Rumsfeld; Brahmajee K Nallamothu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-05-10

5.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

Review 6.  Guidelines for revascularization: The evidence base matures.

Authors:  Robert O Bonow
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

7.  Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.

Authors:  Paul L Hess; Vinay Kini; Wenhui Liu; Paola Roldan; Patrick Autruong; Gary K Grunwald; Colin O'Donnell; Jacob A Doll; P Michael Ho; Steven M Bradley
Journal:  JAMA Netw Open       Date:  2020-04-01

Review 8.  Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis.

Authors:  Michael A Serbin; Gregory F Guzauskas; David L Veenstra
Journal:  J Manag Care Spec Pharm       Date:  2016-08

9.  Assessment of barriers and facilitators in the implementation of appropriate use criteria for elective percutaneous coronary interventions: a qualitative study.

Authors:  Anne Lambert-Kerzner; Charles Maynard; Marina McCreight; Amy Ladebue; Katherine M Williams; Kelty B Fehling; Steven M Bradley
Journal:  BMC Cardiovasc Disord       Date:  2018-08-13       Impact factor: 2.298

10.  Up to 15-Year Survival of Men and Women after Percutaneous Coronary Intervention Paid by the Brazilian Public Healthcare System in the State of Rio de Janeiro, 1999-2010.

Authors:  Christina Grüne de Souza E Silva; Carlos Henrique Klein; Paulo Henrique Godoy; Lucia Helena Alvares Salis; Nelson Albuquerque de Souza E Silva
Journal:  Arq Bras Cardiol       Date:  2018-10-18       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.